AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Febudim ER 40 Tablet

Prescription Icon
Prescription Required

Marketer

Biokindle Lifesciences Pvt Ltd

Salt Composition

Febuxostat (40mg)

Overview Febudim ER 40 Tablet

Febuxostat Extended-Release 40mg tablets manage and prevent gout attacks. Gout results from excessive uric acid buildup, crystallizing in joints, causing inflammation and pain. This medication lowers uric acid levels. It can be taken with or without food. Continue taking it as prescribed, even without symptoms; stopping may worsen gout due to increased crystal formation. Dietary modifications (e.g., limiting alcohol and red meat) and increased fluid intake are beneficial. Common side effects include liver enzyme abnormalities, nausea, arthralgia, and skin rashes. Initially, a temporary flare-up of gout (intense joint pain, warmth, redness) might occur; don't discontinue treatment. Your doctor might prescribe analgesics or other medications to alleviate this. Report any signs of liver dysfunction immediately (persistent nausea, dark urine, jaundice). Inform your doctor about pre-existing heart disease, stroke, thyroid issues, kidney or liver problems before starting treatment. Avoid this medication during pregnancy or breastfeeding; consult your doctor. Regular blood tests monitor liver function during treatment.

Uses of Febudim ER 40 Tablet

Managing Gout

Major Benefits of Febudim ER 40 Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Febudim ER 40 Tablets can be consumed with or without food, although consistent daily timing is recommended.

Common Side effects of Febudim ER 40 Tablet:

  • Nausea
  • Skin rash
  • Abnormal liver function
  • Joint pain
  • Rash

How to use Febudim ER 40 Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Febudim ER 40 Tablets can be consumed with or without food, however, consistent daily timing is recommended.

How Febudim ER 40 Tablet works:

Febuxostat extended-release 40 mg tablets inhibit xanthine oxidase, thereby lowering serum uric acid levels, the causative agent in gout.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Use caution when drinking alcohol while taking Febudim ER 40mg tablets. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Febudim ER 40 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release febuxostat 40 mg tablets are likely not safe for use while breastfeeding. Available data from human studies indicate potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Driving may be impaired by Febudim ER 40 Tablet side effects such as dizziness, drowsiness, blurred vision, or numbness and tingling. These effects can negatively impact your ability to operate a vehicle.

KidneyKidneyCAUTION

Patients with severe kidney impairment should exercise caution when using Febudim ER 40 mg tablets, as dose modification may be necessary. Physician consultation is recommended. Data on the use of Febudim ER 40 mg tablets in such patients is limited.

LiverLiverCAUTION

Patients with severe hepatic impairment should use Febudim ER 40mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended as data on Febudim ER 40mg tablet use in this patient population is limited.

What if you forget to take Febudim ER 40 Tablet :

Should you forget to take a Febudim ER 40 Tablet, ingest it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Febudim ER 40 Tablet

LabelValue
Type of Compound Thiazole-based compound
Potential for Dependence None.
Type of Medication Pain relievers

FAQs on Febudim ER 40 Tablet

Febudis 40 mg extended-release tablets are indicated for adult gout management. This medication is primarily prescribed for individuals who have not responded to allopurinol therapy or cannot tolerate allopurinol. Gout, an arthritic condition, arises from a buildup of uric acid – a naturally occurring body compound – within the joints. This accumulation triggers acute episodes of joint inflammation, characterized by redness, swelling, pain, and warmth in one or more affected joints.
Febudim ER 40 Tablets may produce side effects including atypical liver function test results, diarrhea, headache, skin rash, nausea, and worsening gout symptoms or localized swelling from fluid retention (edema). Serious adverse reactions to Febudim ER 40 Tablets can involve cardiac issues, gout attacks, hepatic complications, and severe dermatological or allergic responses. Seek immediate medical attention should any serious side effect occur.
Your doctor will determine the appropriate dosage and treatment length for Febudim ER 40 Tablet, as these vary individually. Gout attack prevention with Febudim ER 40 Tablet may require several months. Discontinue Febudim ER 40 Tablet only under your doctor's guidance, regardless of improvement in symptoms.
Take one Febudim ER 40 Tablet daily. The time of day is flexible, but consistency is key for reliable blood levels. Consumption with or without food is acceptable.
Extended-release febuxostat 40 mg tablets can sometimes impact kidney function, although this is infrequent. Potential effects include hematuria, increased urinary frequency, nephrolithiasis, abnormal urinalysis (specifically, proteinuria), and diminished renal function. In rare instances, decreased or altered urine output may occur secondary to tubulointerstitial nephritis. Seek medical advice if you notice any worsening of your kidney health.
Never discontinue Febudim ER 40 Tablet use without consulting your physician, regardless of improvement in your condition. Ceasing treatment could elevate uric acid concentrations, potentially exacerbating symptoms through the generation of fresh urate crystals in and around your joints and kidneys.
Febudim ER 40 Tablet carries a risk of potentially fatal cardiac complications. These can manifest as chest pain, dyspnea, lightheadedness, syncope, palpitations, arrhythmias, unilateral weakness or numbness, dysarthria, sudden visual disturbances, or severe headache. Seek immediate medical attention should any of these symptoms arise.
Liver complications are a potential side effect of Febudim ER 40 Tablet. To monitor liver function, your physician might recommend routine blood tests prior to and throughout your treatment. Report any persistent fatigue, right-sided abdominal pain or tenderness, or appetite loss to your doctor. Additional signs to watch for include darkened or tea-colored urine, and yellowing of the skin or whites of the eyes (jaundice).
Febudim ER 40 Tablet
131
MRP 159
17% off